Last reviewed · How we verify

NCT02161445: STA/AHF

Systolic Time Intervals in the Diagnosis of Heart Failure in Emergency Departement

Completed Last updated 1 July 2020
What this trial tests

trial testing the acoustic cardiographic parameters were calculated in Dyspnea in 530 participants. Completed in 31 December 2019.

Timeline
2 October 2012
Primary endpoint
31 December 2017
31 December 2019

Quick facts

Lead sponsorUniversity of Monastir
StatusCompleted
Study typeOBSERVATIONAL
Enrollment530
Start date2 October 2012
Primary completion31 December 2017
Estimated completion31 December 2019
Sites1 location across Tunisia

Drugs / interventions tested

Conditions studied

Sponsor

University of Monastir

Who can join

18 and older, any sex, with Dyspnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the gold standard for the diagnostic of acute heart failure is based on clinical, biological (BNP levels) and echocardiographic findings, but still in some cases, the diagnosis is difficult and requires further investigations. BNP dosages and echocardiography are not always available in many medical centers, especially in emergency departements, and are expensive. we investigated the use of alternative methods, such as the systolic time intervals (STI), in the diagnosis of acute heart failure (AHF) in emergency departement patients consulting for dyspnea.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Dyspnea

Currently open trials in the same condition.

Other University of Monastir trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02161445.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing